within Pharmacolibrary.Drugs.ATC.S;

model S01BA16
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 0.05 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S01BA16</td></tr><td>route:</td><td>ocular</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Difluprednate is a synthetic corticosteroid used primarily as an ophthalmic emulsion for the treatment of inflammation and pain associated with ocular surgery, as well as for the treatment of endogenous anterior uveitis. It is an FDA-approved steroid for ophthalmic use and acts by suppressing inflammation and immune responses in the eye.</p><h4>Pharmacokinetics</h4><p>No published clinical pharmacokinetic data exist for difluprednate in humans; available data indicate that after ocular administration, difluprednate is rapidly metabolized to its active metabolite (difluoroprednisolone butyrate) with minimal systemic absorption.</p><h4>References</h4><ol><li><p>Mulki, L, &amp; Foster, CS (2011). Difluprednate for inflammatory eye disorders. <i>Drugs of today (Barcelona, Spain : 1998)</i> 47(5) 327–333. DOI:<a href=&quot;https://doi.org/10.1358/dot.2011.47.5.1590791&quot;>10.1358/dot.2011.47.5.1590791</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22013563/&quot;>https://pubmed.ncbi.nlm.nih.gov/22013563</a></p></li><li><p>Tajika, T, et al., &amp; Sakaki, H (2011). Ocular distribution of difluprednate ophthalmic emulsion 0.05% in rabbits. <i>Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics</i> 27(1) 43–49. DOI:<a href=&quot;https://doi.org/10.1089/jop.2010.0093&quot;>10.1089/jop.2010.0093</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21118027/&quot;>https://pubmed.ncbi.nlm.nih.gov/21118027</a></p></li><li><p>Tajika, T, et al., &amp; Sakaki, H (2010). Metabolic profiles of difluprednate in rabbit ocular tissues after instillation of difluprednate ophthalmic emulsion. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 40(8) 569–577. DOI:<a href=&quot;https://doi.org/10.3109/00498254.2010.490308&quot;>10.3109/00498254.2010.490308</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20509750/&quot;>https://pubmed.ncbi.nlm.nih.gov/20509750</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S01BA16;
